OSPN(OSPN)
OSPN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $246M | $254M |
| Low | $246M | $254M |
| High | $247M | $254M |
| EBITDA Avg | $140M | $145M |
| Low | $140M | $144M |
| High | $141M | $145M |
| EBIT Avg | $126M | $129M |
| Low | $125M | $129M |
| High | $126M | $130M |
| Net Income Avg | $47M | $50M |
| Low | $45M | $45M |
| High | $49M | $55M |
| EPS Avg | $1.22 | $1.31 |
| Low | $1.17 | $1.17 |
| High | $1.27 | $1.44 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $59M | $63M | $67M | $61M | $61M | $65M |
| Low | $58M | $62M | $66M | $60M | $60M | $64M |
| High | $60M | $64M | $69M | $62M | $62M | $66M |
| EBITDA Avg | $34M | $36M | $38M | $35M | $35M | $37M |
| Low | $33M | $35M | $38M | $34M | $34M | $36M |
| High | $34M | $37M | $39M | $35M | $36M | $38M |
| EBIT Avg | $30M | $32M | $34M | $31M | $31M | $33M |
| Low | $30M | $32M | $34M | $30M | $31M | $33M |
| High | $30M | $33M | $35M | $31M | $32M | $34M |
| Net Income Avg | $11M | $12M | $14M | $11M | $12M | $13M |
| Low | $10M | $12M | $14M | $11M | $12M | $13M |
| High | $12M | $12M | $15M | $11M | $12M | $13M |
| EPS Avg | $0.29 | $0.31 | $0.37 | $0.29 | $0.31 | $0.34 |
| Low | $0.26 | $0.31 | $0.36 | $0.28 | $0.30 | $0.33 |
| High | $0.31 | $0.32 | $0.38 | $0.30 | $0.32 | $0.35 |
| Analysts (Rev / EPS) | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |